Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 17.58%-206.94K | -386.28%-147.51K | 72.95%-160.84K | 63.37%-104.6K | 91.68%143.33K | -346.13%-251.09K | 110.61%51.53K | 9.25%-594.52K | -285.58K | 74.78K |
| Net income from continuing operations | -1.51%-184.21K | -14.15%-222.19K | -78.54%-722.56K | -16.88%-124.31K | -230.21%-222.14K | -7.76%-181.47K | 35.24%-194.64K | 59.50%-404.7K | ---106.36K | --170.6K |
| Operating gains losses | ---- | ---- | 93.55%-449 | ---- | ---- | ---- | ---- | ---6.96K | ---- | ---- |
| Depreciation and amortization | 1.13%2.15K | 1.28%2.13K | 36.52%8.59K | 4.97%2.2K | 3.24%2.17K | --2.12K | --2.11K | --6.3K | --2.09K | --2.1K |
| Remuneration paid in stock | --0 | 97.61%108.8K | --55.06K | --0 | --0 | --0 | --55.06K | --0 | --0 | --0 |
| Other non cashItems | ---37.93K | ---14.3K | 14.53%-44.1K | ---700 | ---- | ---- | ---- | 0.83%-51.6K | --0 | ---24K |
| Change In working capital | 118.20%13.06K | -111.61%-21.95K | 494.48%542.62K | 110.70%18.66K | 650.15%406.7K | -124.24%-71.74K | 202.06%189K | -373.14%-137.55K | ---174.36K | ---73.93K |
| -Change in receivables | -138.35%-13.74K | -101.52%-2.22K | 219.80%178.62K | 101.31%2.46K | ---6.22K | 2.45%35.82K | 3,933.80%146.55K | -410.00%-149.1K | ---187.7K | --0 |
| -Change in prepaid assets | 102.98%4.34K | -2,899.54%-32.55K | 15,496.30%4.16K | 12.65%-5.97K | 52,185.00%156.86K | -161.95%-145.64K | 99.53%-1.09K | 99.88%-27 | ---6.84K | --300 |
| -Change in payables and accrued expense | -41.01%22.46K | -70.56%12.82K | 3,009.36%359.85K | 9.86%22.17K | 444.98%256.06K | 47.11%38.07K | 9.57%43.54K | -88.66%11.57K | --20.18K | ---74.23K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 17.58%-206.94K | -386.28%-147.51K | 72.95%-160.84K | 63.37%-104.6K | 91.68%143.33K | -346.13%-251.09K | 110.61%51.53K | 9.25%-594.52K | ---285.58K | --74.78K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 92.47%-11.36K | -67.76K | -464.51%-354.2K | -278.25%-170.93K | 60.73%-32.39K | -94.31%-150.89K | 0 | 85.77%-62.75K | 95.89K | -82.47K |
| Net PPE purchase and sale | ---11.36K | ---67.76K | -211.93%-195.72K | -274.17%-167.01K | 65.19%-28.71K | --0 | --0 | 85.77%-62.75K | --95.89K | ---82.47K |
| Net other investing changes | ---- | ---- | ---158.48K | ---3.91K | ---157.68K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -465.16%-11.36K | ---67.76K | -464.51%-354.2K | -278.25%-170.93K | -126.01%-186.39K | 104.01%3.11K | --0 | 85.77%-62.75K | --95.89K | ---82.47K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 6,046.70%307.34K | 38.71%181.63K | 149.02%474.72K | 698.99%67.39K | 271.4K | 177.11%5K | -37.16%130.94K | -80.56%190.64K | -11.25K | 0 |
| Net issuance payments of debt | ---- | ---- | --5K | --0 | --0 | ---- | ---- | --0 | ---- | ---- |
| Net common stock issuance | --328.24K | -37.95%84K | 127.98%474.78K | --139.33K | --200.07K | --0 | -34.99%135.38K | -79.59%208.25K | --0 | --0 |
| Proceeds from stock option exercised by employees | --0 | --63.5K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net other financing activities | ---19.9K | 868.58%34.13K | 71.28%-5.06K | -539.50%-71.94K | --71.33K | --0 | -3,769.42%-4.44K | 55.19%-17.61K | ---11.25K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 6,066.70%308.34K | 38.71%181.63K | 149.02%474.72K | 698.99%67.39K | --271.4K | 177.11%5K | -37.16%130.94K | -80.56%190.64K | ---11.25K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -98.81%3.08K | -52.34%36.72K | -85.83%77.04K | -11.92%244.86K | -94.22%16.52K | -3.10%259.5K | -85.83%77.04K | -17.48%543.67K | --277.98K | --285.68K |
| Current changes in cash | 137.05%90.04K | -118.44%-33.64K | 91.36%-40.32K | -3.58%-208.14K | 3,068.91%228.34K | -1,459.19%-242.98K | 166.14%182.46K | -305.09%-466.63K | ---200.94K | ---7.69K |
| End cash Position | 463.59%93.11K | -98.81%3.08K | -52.34%36.72K | -52.34%36.72K | -11.92%244.86K | -94.22%16.52K | -3.10%259.5K | -85.83%77.04K | --77.04K | --277.98K |
| Free cash from | 13.06%-218.3K | -517.79%-215.27K | 45.75%-356.56K | -43.19%-271.62K | 1,590.37%114.62K | -1,071.50%-251.09K | 110.61%51.53K | 40.03%-657.26K | ---189.69K | ---7.69K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.